DNA methylation profiles of samples included in the EORTC 26091 TAVAREC trial
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
The TAVAREC trial was a randomized, open-label phase 2 trial assessing the benefit of the addition of the angiogenesis inhibitor bevacizumab to treatment with temozolomide in patients with a first enhancing recurrence of WHO grade 2 or 3 glioma without 1p/19q codeletion. We evaluated the prognostic significance of genome wide DNA methylation profiles and copy number variations on the TAVAREC trial samples.EGA study EGAS00001006015
创建时间：
2022-03-03
